Fedha

Hisa unazofuatilia
EW:NYSE
Edwards Lifesciences Corp
US$ 85.21
+1.10%
(+0.93) Siku 1
US$ 85.21
0.00% (0.00)
Baada ya saa
Imefungwa: 9 Okt, 16:00:05 GMT -4  ·   USD
Alama zote
AlamaBeiTofautiTofauti ya asilimia
Inatayarisha maarifa maarufu ya EW...
Fungua
US$ 84.60
Juu
US$ 85.34
Chini
US$ 83.22
Mtaji wa soko
49.12B
Wastani wa kiasi cha mauzo
3.43M
Kiasi cha mauzo ya hisa
3.89M
Uwiano wa bei ya hisa na mapato kwa kila hisa
49.30
Juu kwa wiki 52
US$ 96.29
Chini kwa wiki 52
US$ 72.30
EPS
US$ 1.73
Beta
0.87
Hisa za wawekezaji
576.40M
Idadi ya wafanyakazi
elfu 16
Fungua
US$ 84.60
Juu
US$ 85.34
Chini
US$ 83.22
Mtaji wa soko
49.12B
Wastani wa kiasi cha mauzo
3.43M
Kiasi cha mauzo ya hisa
3.89M
Uwiano wa bei ya hisa na mapato kwa kila hisa
49.30
Juu kwa wiki 52
US$ 96.29
Chini kwa wiki 52
US$ 72.30
EPS
US$ 1.73
Beta
0.87
Hisa za wawekezaji
576.40M
Idadi ya wafanyakazi
elfu 16
Habari
Kutoka kwenye vyanzo vya wavuti na washirika wa habari
Wasifu
Edwards Lifesciences Corporation is an American medical technology company headquartered in Irvine, California, specializing in tissue heart valves and transcatheter technologies for the treatment of structural heart disease. The company has manufacturing facilities at the Irvine headquarters, as well as in Draper, Utah; Costa Rica; Singapore; and Limerick, Ireland. The company is also constructing a manufacturing plant in Moncada, near Valencia, Spain, with a €150 million investment. Production is scheduled to begin in 2027. Wikipedia
Kuhusu Edwards Lifesciences Corp
Afisa Mkuu Mtendaji (CEO)-
Wafanyakazielfu 16
Lilianzishwa1958
Makao makuuIrvine, California, Marekani
Sekta-
Tovutiedwards.com
Ukadiriaji wa mchanganuzi
Kulingana na wachanganuzi 16 waliotoa ukadiriaji wa hisa kwa EW katika miezi 3 iliyopita
Imenunuliwa sana
Nunua
13
Shikilia
3
Uza
0
Utabiri wa miezi 12
Kulingana na wachanganuzi 16 wa Wall Street wanaotoa makadirio ya bei ya miezi 12 ya EW katika miezi 3 iliyopita.
Juu kabisa
Ya sasa US$ 85.21
US$ 110.00 (+29.09%)
Wastani
US$ 104.00 (+22.05%)
Chini kabisa
US$ 85.00 (-0.25%)
Mchanganuzi
Unaopendekezwa
Kitendo
Bei lengwa
Unaokadiriwa
Tarehe
Patrick Wood
UBS
Buy
Maintained
US$ 110.00
+29.1%
10/07/2026
Matt Miksic
Barclays
Buy
Maintained
US$ 110.00
+29.1%
10/07/2026
Tycho Peterson
Jefferies
Buy
Initiated
US$ 110.00
+29.1%
10/07/2026
Joanne Wuensch
Citi
Buy
Maintained
US$ 110.00
+29.1%
10/05/2026
Kendall Au
RBC Capital
Buy
Maintained
US$ 110.00
+29.1%
10/01/2026
Mike Kratky
Leerink Partners
Buy
Reiterated
US$ 101.00
+18.5%
09/28/2026
Adam Maeder
Piper Sandler
Buy
Maintained
US$ 101.00
+18.5%
09/21/2026
Matthew Taylor
Jefferies
Buy
Maintained
US$ 105.00
+23.2%
09/11/2026
Marie Thibault
BTIG
Buy
Maintained
US$ 110.00
+29.1%
09/10/2026
Brandon Vazquez
William Blair
Buy
Maintained
-
-
09/10/2026
William Plovanic
Canaccord Genuity
Hold
Maintained
US$ 85.00
-0.2%
08/03/2026
Robbie Marcus
J.P. Morgan
Buy
Maintained
US$ 105.00
+23.2%
07/28/2026
Rick Wise
Stifel Nicolaus
Buy
Maintained
US$ 110.00
+29.1%
07/24/2026
Suraj Kalia
Oppenheimer
Hold
Maintained
-
-
07/24/2026
Richard Newitter
Truist Financial
Hold
Reiterated
US$ 95.00
+11.5%
07/24/2026
Shagun Singh Chadha
RBC Capital
Buy
Reiterated
US$ 110.00
+29.1%
07/23/2026
Travis Steed
Bank of America Securities
Buy
Maintained
US$ 100.00
+17.4%
07/21/2026
Josh Jennings
TD Cowen
Buy
Reiterated
US$ 104.00
+22.1%
07/23/2026
Anthony Petrone
Mizuho Securities
Buy
Maintained
US$ 105.00
+23.2%
07/15/2026
Vijay Kumar
Evercore ISI
Buy
Maintained
US$ 100.00
+17.4%
07/06/2026
David Roman
Goldman Sachs
Buy
Maintained
US$ 98.00
+15%
06/15/2026
Krish Sankar
TD Cowen
Buy
Reiterated
US$ 104.00
+22.1%
06/02/2026
David Toung
Argus Research
Buy
Maintained
-
-
05/21/2026
David Rescott
Robert W. Baird
Hold
Maintained
US$ 87.00
+2.1%
04/24/2026
Michael Polark
Wolfe Research
Buy
Upgraded
US$ 92.00
+8%
04/01/2026
Danielle Antalffy
UBS
Hold
Maintained
US$ 90.00
+5.6%
02/12/2026
Larry Biegelsen
Wells Fargo
Buy
Reiterated
US$ 100.00
+17.4%
02/11/2026
Ripoti ya mwisho
23 Jul 2026
Kipindi cha Kifedha
Robo2 2026
US$ 0.78 / US$ 0.74
+5.11%umepitiliza
Mapato dhidi ya makadirio (USD)
1.74B / 1.70B
+2.44%umepitiliza
Mkutano pepe wa kujadili mapato ya robo ya Robo ya 2 ya mwaka wa fedha wa 2026
Inasubiri mkutano pepe wa kujadili mapato
Kwa muhtasari
Maarifa kutoka kwenye ripoti na habari za hivi punde
Ripoti za awaliThamani zote katika USD
Loading Previous Earnings...
Mapato
Mapato halisi
Thamani zote katika USD
Sep 2025
Des 2025
Mac 2026
Jun 2026
Mapato
1.55B
1.57B
1.65B
1.74B
Gharama ya bidhaa zilizouzwa
345.20M
343.00M
362.60M
392.40M
Gharama ya mapato
345.20M
343.00M
362.60M
392.40M
Gharama za utafiti na maendeleo
280.70M
267.70M
263.30M
278.90M
Jumla ya gharama za utafiti na maendeleo
-
-
-
-
Gharama za uuzaji, za jumla na za usimamizi
514.60M
601.20M
522.20M
561.20M
Gharama ya uendeshaji
782.80M
854.60M
771.30M
829.10M
Jumla ya gharama za uendeshaji
1.13B
1.20B
1.13B
1.22B
Mapato ya uendeshaji
425.10M
372.00M
514.70M
519.50M
Mapato mengine yasiyo ya uendeshaji
1.10M
2.30M
69.90M
-25.00M
EBT ikijumuisha vipengee visivyo vya kawaida
348.40M
90.40M
459.00M
519.80M
EBT bila kujumuisha vipengee visivyo vya kawaida
444.50M
464.00M
603.60M
511.10M
Gharama ya kodi ya mapato
56.10M
26.20M
78.30M
278.40M
Kiwango cha kodi kinachotumika
16.10%
28.98%
17.06%
53.56%
Gharama nyingine za uendeshaji
-12.50M
-14.30M
-14.20M
-11.00M
Mapato halisi
291.10M
91.20M
380.70M
241.90M
Kiwango cha faida halisi
18.74%
5.81%
23.09%
13.89%
Mapato kwa kila hisa
0.67
0.58
0.78
0.78
Mapato ya riba na uwekezaji
16.70M
114.20M
17.40M
15.00M
Gharama ya riba
-
-20.40M
-
-
Jumla ya gharama halisi za riba
16.70M
93.80M
17.40M
15.00M
Gharama za kushuka kwa thamani na za kulipa deni
-
-
-
-
Mapato ya kampuni kabla ya riba, kodi, kushuka thamani na kulipa madeni
464.30M
414.70M
555.60M
562.20M
Faida au hasara kutokana na uuzaji wa vipengee
-
-33.90M
-
-
Miamala ya wajuzi wa mambo
Data ya miamala ya watu wenye hisa hutolewa kwenye vyanzo vya washirika wengine. Pata maelezo zaidi
Mjuzi wa mambo
Nafasi
Aina
Tarehe
Hisa
Kiasi
Ukurasa wa 1
Maudhui yaliyotayarishwa kwa AI yanaweza kuwa na makosa. Pata maelezo zaidi
UsaidiziTuma maoniFaraghaSheria na MashartiKanusho
Programu za Google